Events Timeline
No data
News
Valuation Metrics
Financials
Trading Trends
People Also Watch
Frequently Asked Questions
What is Gracell Biotechnologies Inc. American Depositary Shares (GRCL) stock price today?
The current price of GRCL is 0 USD — it has increased 0 % in the last trading day.
What is Gracell Biotechnologies Inc. American Depositary Shares (GRCL)'s business?
Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.
What is the price predicton of GRCL Stock?
Wall Street analysts forecast GRCL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GRCL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Gracell Biotechnologies Inc. American Depositary Shares (GRCL)'s revenue for the last quarter?
Gracell Biotechnologies Inc. American Depositary Shares revenue for the last quarter amounts to NaN USD, decreased % YoY.
What is Gracell Biotechnologies Inc. American Depositary Shares (GRCL)'s earnings per share (EPS) for the last quarter?
Gracell Biotechnologies Inc. American Depositary Shares. EPS for the last quarter amounts to USD, decreased % YoY.
How many employees does Gracell Biotechnologies Inc. American Depositary Shares (GRCL). have?
Gracell Biotechnologies Inc. American Depositary Shares (GRCL) has 314 emplpoyees as of January 16 2026.
What is Gracell Biotechnologies Inc. American Depositary Shares (GRCL) market cap?
Today GRCL has the market capitalization of 989.87M USD.